Viruses and Cytotoxic T Lymphocytes in Type 1 Diabetes

被引:0
|
作者
Ken T. Coppieters
Matthias G. von Herrath
机构
[1] The La Jolla Institute for Allergy and Immunology,Type 1 Diabetes Center
来源
Clinical Reviews in Allergy & Immunology | 2011年 / 41卷
关键词
Type 1 diabetes; Autoimmunity; CD8 T cells; CTL; Beta cells;
D O I
暂无
中图分类号
学科分类号
摘要
Histopathological studies on pancreas tissues from individuals with recent-onset type 1 diabetes (T1D) consistently find that CD8 T cells substantially contribute to the formation of islet lesions. CD8 T cells reactive against islet-associated antigens can also be found in blood samples from T1D patients. Mechanistic studies on the pathogenic role of this T cell subset have mostly focused on two animal models, i.e., the non-obese diabetic mouse and the virally induced rat insulin promoter–lymphocytic choriomeningitis virus model. Data were obtained in support of a role for viral infection in expanding a population of diabetogenic cytotoxic T lymphocytes. In view of the theorized association of viral infection with initiation of islet autoimmunity and progression to clinically overt disease, CD8 T cells thus represent an attractive target for immunotherapy. We will review here arguments in favor of a pivotal role for CD8 T cells in driving T1D development and speculate on etiologic agents that may provoke their aberrant activation.
引用
收藏
页码:169 / 178
页数:9
相关论文
共 50 条
  • [32] An Antigenic Threshold for Maintaining Human Immunodeficiency Virus Type 1-specific Cytotoxic T Lymphocytes
    Xia Jin
    Graham Ogg
    Sabstian Bonhoeffer
    Jeffrey Safrit
    Mika Vesanen
    Daniel Bauer
    Donald Chen
    Yunzhen Cao
    Marie-Ange Demoitie
    Linqi Zhang
    Martin Markowitz
    Douglas Nixon
    Andrew McMichael
    David D. Ho
    Molecular Medicine, 2000, 6 : 803 - 809
  • [33] The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies
    Faustman, Denise L.
    Davis, Miriam
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2009, 87 (12): : 1173 - 1178
  • [34] The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies
    Denise L. Faustman
    Miriam Davis
    Journal of Molecular Medicine, 2009, 87 : 1173 - 1178
  • [35] Inhibition of human immunodeficiency virus type 1 replication in primary CD4+ T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes
    Severino, ME
    Sipsas, NV
    Nguyen, PT
    Kalams, SA
    Walker, BD
    Johnson, RP
    Yang, OO
    JOURNAL OF VIROLOGY, 2000, 74 (14) : 6695 - 6699
  • [36] Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes
    Yang, OO
    Kalams, SA
    Rosenzweig, M
    Trocha, A
    Jones, N
    Koziel, M
    Walker, BD
    Johnson, RP
    JOURNAL OF VIROLOGY, 1996, 70 (09) : 5799 - 5806
  • [37] Abnormal Distribution of Gamma-Delta T Lymphocytes and Their Subsets in Type 1 Diabetes
    Zubkiewicz-Kucharska, Agnieszka
    Noczynska, Anna
    Usnarska-Zubkiewicz, Lidia
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (04): : 665 - 671
  • [38] Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes
    Yang, OO
    Nguyen, PT
    Kalams, SA
    Dorfman, T
    Göttlinger, HG
    Stewart, S
    Chen, ISY
    Threlkeld, S
    Walker, BD
    JOURNAL OF VIROLOGY, 2002, 76 (04) : 1626 - 1631
  • [39] In vivo production of Rof and Tof proteins of HTLV type 1:: Evidence from cytotoxic T lymphocytes
    Pique, C
    Dokhelar, MC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (16) : 1783 - 1786
  • [40] An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes
    Jin, X
    Ogg, G
    Bonhoeffer, S
    Safrit, J
    Vesanen, M
    Bauer, D
    Chen, D
    Cao, YZ
    Demoitie, MA
    Zhang, LQ
    Markowitz, M
    Nixon, D
    McMichael, A
    Ho, DD
    MOLECULAR MEDICINE, 2000, 6 (09) : 803 - 809